C-K3FWadvocacy, rejuvenation biotechnology, research funding
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Evaluate a 15-strain live biotherapeutic product for recurrent Clostridioides difficile infection.
Randomized phase 1b trial comparing 15-strain live biotherapeutic product with same-donor fecal microbiota transplant.
Listed as a randomized phase 1b trial publication.
Understand how the circadian clock component BMAL1 enhances macrophage inflammation.
Mechanistic study of BMAL1 nuclear translocation of peroxisomal beta-oxidation enzyme MFP2.
Listed as a 2026 publication title.
Title states BMAL1 enhances macrophage inflammation through nuclear translocation of MFP2.
Derive an aging clock from transcriptomic data across species.
Cross-species transcriptomic aging clock.
Listed as a 2026 filtered publication.
Investigate FAM162A as a regulator of mitochondrial structure, dynamics, bioenergetics, cellular protection, and longevity.
Mechanistic study of FAM162A mitochondrial regulation.
Listed as a filtered publication.
Title identifies FAM162A as a key regulator driving cellular protection and longevity.
Deliver longevity, aging research, biotechnology, advocacy, fundraising, and rejuvenation biotechnology updates to subscribers.
Weekly digital newsletter and archive covering human longevity, aging research, biotechnology, events, advocacy, and fundraising initiatives.
Newsletter archive page states the newsletter is delivered weekly to thousands of subscribers.
Deliver weekly longevity, aging research, biotechnology, advocacy, fundraising, and community updates to subscribers.
Newsletter publication and archive covering human longevity, aging research, biotechnology, medical advances, events, advocacy, and fundraising initiatives.
Newsletter archive and sign-up page are publicly listed as delivered weekly to thousands of subscribers.
Advocate for longer, healthier lives by promoting rejuvenation biotechnology, aging research, and funding for work aimed at repairing and reversing root causes of aging.
Public advocacy and news coverage focused on rejuvenation biotechnology topics including senolytics, stem cell therapies, aging clocks, metabolism, and SENS-style rejuvenation research.
Site analysis identifies ongoing 2026 coverage of aging research publications and directs readers to fund meaningful aging research.
Direct readers toward advocacy and fundraising initiatives intended to advance rejuvenation biotechnology and aging research.
Public funding-advocacy resource linking readers to ways to support aging research and rejuvenation biotechnology initiatives.
Listed prominently on Fight Aging! pages and newsletters as a public action/resource area.
Encourage support for meaningful aging research and help advance rejuvenation biotechnology.
Advocacy and fundraising-oriented site program directing readers to fund research relevant to the root causes of aging and rejuvenation biotechnology.
Public site navigation and newsletter page reference Fund Research, Fund Meaningful Aging Research, and advocacy and fundraising initiatives to help advance rejuvenation biotechnology.
Investigate whether gut microbiota-modulated glutamic acid rejuvenates oocyte quality affected by advanced reproductive age.
Microbiota-linked glutamic acid intervention or mechanism study.
Listed as a filtered publication.
Title states glutamic acid rejuvenates oocyte quality deteriorated by advanced reproductive age.
Provide services related to the longevity industry and starting longevity biotechnology companies.
Consulting/service offering referenced alongside resources including "How to Start a Longevity Biotech Company."
Listed in public site navigation/services resources.
Assess whether low dose continuous rapamycin favorably alters the aging immune system.
Rapamycin intervention described by publication title.
Listed as a 2026 filtered publication.
Title states low dose continuous rapamycin favorably alters the aging immune system.
Evaluate distinct metabolic adjustment approaches that may increase longevity.
Comparative research on multiple metabolic adjustment strategies.
Listed as a 2026 publication on metabolic adjustment for greater longevity.
Educate readers on damage-based root causes of aging, including cross-links, amyloid buildup, immune system failure, lysosomal decline, mitochondrial DNA damage, nuclear DNA damage, and senescent cell buildup.
Public educational resource and taxonomy of aging-damage categories used to frame rejuvenation biotechnology advocacy.
Publicly listed as a Fight Aging! resource area under "The Root Causes of Aging."
Evaluate same donor fecal microbiota transplant for recurrent Clostridioides difficile infection.
Randomized phase 1b trial comparing same-donor fecal microbiota transplant with a 15-strain live biotherapeutic product.
Listed as a randomized phase 1b trial publication.
Develop or evaluate small molecule PAI-1 inhibitors to slow aging.
Small molecule inhibition of PAI-1.
Listed as a 2026 filtered publication.
Measure or model biological aging using multi-omics data.
Multi-omics aging clock.
Listed as a 2026 publication: StackAge is a Multi-Omics Aging Clock.
Extend healthspan and lifespan by combining senolytic and regenerative interventions.
Senolytic-regenerative therapeutic approach described in a 2026 publication title.
Listed as a 2026 paper on the site.
Title states the therapy significantly extends healthspan and lifespan.